Abstract
Background
Bariatric surgery is an effective treatment for severe obesity; however, postoperative venous thromboembolism (VTE) remains a leading cause of morbidity and mortality. The objective of this study is to develop a tool to stratify individuals undergoing laparoscopic bariatric surgery according to their 30-day VTE risk.
Methods
This is a retrospective cohort study of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database. This registry collects data specific for metabolic or bariatric surgery with 30-day outcomes from 791 centers. Individuals undergoing primary laparoscopic Roux-en-Y gastric bypass (LRYGB) or laparoscopic sleeve gastrectomy (LSG) were included. Characteristics associated with 30-day VTE were identified using univariate and multivariable analyses. A predictive model, BariClot, was derived from a randomly-generated derivation cohort using a forward selection algorithm. BariClot’s robustness was tested against a validation cohort of subjects not included in the derivation cohort. The calibration and discrimination of two previously published VTE risk tools were assessed in the MBSAQIP population and compared to BariClot.
Results
A total of 274,221 patients underwent LRYGB or LSG. Overall, 1106 (0.4%) patients developed VTE, 452 (0.2%) developed pulmonary embolism, and 43 (0.02%) died due to VTE. VTE was the most commonly identified cause of 30-day mortality. A prediction model to assess for risk of VTE, BariClot, was derived and validated. BariClot consists of history of VTE, operative time, race, and functional status. It stratifies individuals into very high (> 2%), high (1–2%), medium (0.3–1%), and low risk groups (< 0.3%). This model accurately predicted events in the validation cohort and outperformed previously published scoring systems.
Conclusions
BariClot is a predictive tool that stratifies individuals undergoing bariatric surgery based on 30-day VTE risk. Stratifying low- and high-risk populations for VTE allows for informed clinical decision-making and potentially enables further research on customized prophylactic measures for low- and high-risk populations.
Similar content being viewed by others
References
Sjöström L (2013) Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med 273:219–234. https://doi.org/10.1111/joim.12012
Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N (2015) Bariatric surgery worldwide 2013. Obes Surg 25:1822–1832. https://doi.org/10.1007/s11695-015-1657-z
Becattini C, Agnelli G, Manina G, Noya G, Rondelli F (2012) Venous thromboembolism after laparoscopic bariatric surgery for morbid obesity: clinical burden and prevention. Surg Obes Relat Dis 8:108–115. https://doi.org/10.1016/J.SOARD.2011.09.005
Stein PD, Beemath A, Olson RE (2005) Obesity as a risk factor in venous thromboembolism. Am J Med 118:978–980. https://doi.org/10.1016/j.amjmed.2005.03.012
Ambrosetti M, Lucioni A, Ageno W, Conti S, Neri M (2004) Is venous thromboembolism more frequent in patients with obstructive sleep apnea syndrome? J Thromb Haemost 2:1858–1860. https://doi.org/10.1111/j.1538-7836.2004.00913.x
Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW (2008) Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 117:93–102. https://doi.org/10.1161/CIRCULATIONAHA.107.709204
Gonzalez QH, Tishler DS, Plata-Munoz JJ, Bondora A, Vickers SM, Leath T, Clements RH (2004) Incidence of clinically evident deep venous thrombosis after Laroscopic Roux-en-Y Gastric bypass. Surg Endosc 18:1082–1084. https://doi.org/10.1007/s00464-003-8202-1
Gonzalez R, Haines K, Nelson LG, Gallagher SF, Murr MM (2006) Predictive factors of thromboembolic events in patients undergoing Roux-en-Y gastric bypass. Surg Obes Relat Dis 2:30–35. https://doi.org/10.1016/J.SOARD.2005.10.003
Hamad GG, Choban PS (2005) Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study. Obes Surg 15:1368–1374. https://doi.org/10.1381/096089205774859245
Miller MT, Rovito PF (2004) An Approach to venous thromboembolism prophylaxis in laparoscopic Roux-en-Y gastric bypass surgery. Obes Surg 14:731–737. https://doi.org/10.1381/0960892041590944
Mukherjee D, Lidor AO, Chu KM, Gearhart SL, Haut ER, Chang DC (2008) Postoperative venous thromboembolism rates vary significantly after different types of major abdominal operations. J Gastrointest Surg 12:2015–2022. https://doi.org/10.1007/s11605-008-0600-1
Prystowsky JB, Morasch MD, Eskandari MK, Hungness ES, Nagle AP (2005) Prospective analysis of the incidence of deep venous thrombosis in bariatric surgery patients. Surgery 138:759–765. https://doi.org/10.1016/J.SURG.2005.07.024
Raftopoulos I, Martindale C, Cronin A, Steinberg J (2008) The effect of extended post-discharge chemical thromboprophylaxis on venous thromboembolism rates after bariatric surgery: a prospective comparison trial. Surg Endosc 22:2384–2391. https://doi.org/10.1007/s00464-008-0031-9
Sapala JA, Wood MH, Schuhknecht MP, Sapala MA (2003) Fatal pulmonary embolism after bariatric operations for morbid obesity: a 24-year retrospective analysis. Obes Surg 13:819–825. https://doi.org/10.1381/096089203322618588
Morino M, Toppino M, Forestieri P, Angrisani L, Allaix ME, Scopinaro N (2007) Mortality after bariatric surgery. Ann Surg 246:1002–1009. https://doi.org/10.1097/SLA.0b013e31815c404e
American Society for Metabolic T, Surgery Clinical Issues Committee B (2013) ASMBS updated position statement on prophylactic measures to reduce the risk of venous thromboembolism in bariatric surgery patients The American Society for Metabolic and Bariatric Surgery Clinical Issues Committee*. Surg Obes Relat Dis 9:493–497. https://doi.org/10.1016/j.soard.2013.03.006
Finks JF, English WJ, Carlin AM, Krause KR, Share DA, Banerjee M, Birkmeyer JD, Birkmeyer NJ (2012) Predicting risk for venous thromboembolism with bariatric surgery. Ann Surg 255:1100–1104. https://doi.org/10.1097/SLA.0b013e31825659d4
Caprini JA (2005) Thrombosis risk assessment as a guide to quality patient care. Dis Mon 51:70–78. https://doi.org/10.1016/j.disamonth.2005.02.003
Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA, Caprini JA (2010) A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg 251:344–350. https://doi.org/10.1097/SLA.0b013e3181b7fca6
2016 MBSAQIP Standards Manual. https://www.facs.org/quality-programs/mbsaqip/standards. Accessed 24 Jul 2017
StataCorp (2015) Stata statistical software: release 14. StataCorp LP, College Station, TX
DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837. https://doi.org/10.2307/2531595
Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (2017) MBSAQIP PUF variables and definitions. https://www.facs.org/quality-programs/mbsaqip/participant-use. Accessed 22 Dec 2017
Virchow R (1862) Gesammelte abhandlungen zur wissenschaftlichen medicin von Rudolf Virchow. G. Grotesche Buchhandlung
Kroegel C, Reissig A (2003) Principle mechanisms underlying venous thromboembolism: Epidemiology, risk factors, pathophysiology and pathogenesis. Respiration 70:7–30
Dowling NF, Austin H, Dilley A, Whitsett C, Evatt BL, Hooper WC (2003) The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study1. J Thromb Haemost 1:80–87. https://doi.org/10.1046/j.1538-7836.2003.00031.x
White RH, Zhou H, Murin S, Harvey D (2005) Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 93:298–305. https://doi.org/10.1160/TH04-08-0506
White RH, Zhou H, Romano PS (1998) Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 128:737–740. https://doi.org/10.7326/0003-4819-128-9-199805010-00006
Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR (2002) Cardiovascular risk factors and venous thromboembolism incidence. Arch Intern Med 162:1182. https://doi.org/10.1001/archinte.162.10.1182
Heit JA, Beckman MG, Bockenstedt PL, Grant AM, Key NS, Kulkarni R, Manco-Johnson MJ, Moll S, Ortel TL, Philipp CS (2010) Comparison of characteristics from White- and Black-Americans with venous thromboembolism: a cross-sectional study. Am J Hematol 85:467–471. https://doi.org/10.1002/ajh.21735
Frantzides CT, Welle SN, Ruff TM, Frantzides AT (2012) Routine anticoagulation for venous thromboembolism prevention following laparoscopic gastric bypass. JSLS J Soc Laparoendosc Surg 16:33–37. https://doi.org/10.4293/108680812X13291597716906
Clements RH, Yellumahanthi K, Ballem N, Wesley M, Bland KI (2009) Pharmacologic prophylaxis against venous thromboembolic complications is not mandatory for all laparoscopic Roux-en-Y gastric bypass procedures. J Am Coll Surg 208:917–921. https://doi.org/10.1016/J.JAMCOLLSURG.2009.01.034
Magee CJ, Barry J, Javed S, Macadam R, Kerrigan D (2010) Extended thromboprophylaxis reduces incidence of postoperative venous thromboembolism in laparoscopic bariatric surgery. Surg Obes Relat Dis 6:322–325. https://doi.org/10.1016/J.SOARD.2010.02.046
Borkgren-Okonek MJ, Hart RW, Pantano JE, Rantis PC, Guske PJ, Kane JM, Gordon N, Sambol NC (2008) Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity. Surg Obes Relat Dis 4:625–631. https://doi.org/10.1016/J.SOARD.2007.11.010
Bergqvist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Le Moigne-Amrani A, Dietrich-Neto F (2002) Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 346:975–980. https://doi.org/10.1056/NEJMoa012385
Aminian A, Andalib A, Khorgami Z, Cetin D, Burguera B, Bartholomew J, Brethauer SA, Schauer PR (2017) Who should get extended thromboprophylaxis after bariatric surgery? Ann Surg 265:143–150. https://doi.org/10.1097/SLA.0000000000001686
Brotman DJ, Shihab HM, Prakasa KR, Kebede S, Haut ER, Sharma R, Shermock K, Chelladurai Y, Singh S, Segal JB (2013) Pharmacologic and mechanical strategies for preventing venous thromboembolism after bariatric surgery. JAMA Surg 148:675. https://doi.org/10.1001/jamasurg.2013.72
Scholten DJ, Hoedema RM, Scholten SE (2002) A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg 12:19–24. https://doi.org/10.1381/096089202321144522
Singh K, Podolsky ER, Um S, Saba S, Saeed I, Aggarwal L, Zaya M, Castellanos A (2012) Evaluating the safety and efficacy of BMI-based preoperative administration of low-molecular-weight heparin in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery. Obes Surg 22:47–51. https://doi.org/10.1007/s11695-011-0397-y
Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, Samama CM (2012) Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e227S–e277S. https://doi.org/10.1378/CHEST.11-2297
Bilimoria KY, Liu Y, Paruch JL, Zhou L, Kmiecik TE, Ko CY, Cohen ME (2013) Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg 217:833–842.e3. https://doi.org/10.1016/J.JAMCOLLSURG.2013.07.385
Liu Y, Cohen ME, Ko CY, Bilimoria KY, Hall BL (2016) Considerations in releasing equations for the American College of Surgeons NSQIP surgical risk calculator: in reply to Wanderer and Ehrenfeld. J Am Coll Surg 223:674–675. https://doi.org/10.1016/J.JAMCOLLSURG.2016.06.009
Wanderer JP, Ehrenfeld JM (2016) Toward external validation and routine clinical use of the American College of surgeons NSQIP surgical risk calculator. J Am Coll Surg 223:674. https://doi.org/10.1016/J.JAMCOLLSURG.2016.06.010
Winegar DA, Sherif B, Pate V, DeMaria EJ (2011) Venous thromboembolism after bariatric surgery performed by Bariatric Surgery Center of excellence participants: analysis of the Bariatric outcomes longitudinal database. Surg Obes Relat Dis 7:181–188. https://doi.org/10.1016/J.SOARD.2010.12.008
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Drs. Jerry T. Dang, Noah Switzer, Megan Delisle, Michael Laffin, Richdeep Gill, Daniel W. Birch, and Shahzeer Karmali have no conflict of interest or financial ties to disclose.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Dang, J.T., Switzer, N., Delisle, M. et al. Predicting venous thromboembolism following laparoscopic bariatric surgery: development of the BariClot tool using the MBSAQIP database. Surg Endosc 33, 821–831 (2019). https://doi.org/10.1007/s00464-018-6348-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-018-6348-0